Patents
Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848)
02/2011
02/24/2011WO2010129057A8 Tetracycline compounds
02/24/2011US20110044965 L-citrulline for treating endothelial dysfunction and erectile dysfunction
02/17/2011WO2011019928A1 Modularized system and method for urea production using stranded natural gas
02/17/2011WO2010080795A8 Hydrogen peroxide complexes and their use in the cure system of anaerobic adhesives
02/17/2011WO2010065902A3 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting psma
02/17/2011US20110040102 Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1 (vr1) receptors
02/17/2011US20110039819 Substituted phenoxybenzamides
02/17/2011US20110039714 Probes, Systems, and Methods for Drug Discovery
02/17/2011CA2770801A1 Pesticidal carboxamides
02/17/2011CA2770705A1 Modularized system and method for urea production using stranded natural gas
02/16/2011CN101432268B Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the ss2 adrenergic receptor
02/15/2011US7888470 Chimeric binding protein for use in identifying compounds which respond to umami taste stimuli and sweet taste stimuli
02/10/2011WO2011017201A2 Dp2 antagonist and uses thereof
02/10/2011CA2768587A1 Dp2 antagonist and uses thereof
02/09/2011EP2280933A1 2 -aminotetralin derivatives as mu opioid receptor antagonists
02/09/2011EP2280696A1 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
02/03/2011US20110028559 Substituted fluoroethyl ureas as alpha 2 adrenergic agents
02/03/2011US20110028442 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the beta2 adrenergic receptor
02/02/2011EP2279170A1 Process for increasing the capacity of an existing urea plant
02/02/2011CN1838953B 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
02/02/2011CN101333176B Method for preparing substituent urea and co-producing hydrochloride of corresponding amines
02/01/2011CA2451206C Urea derivatives with antiproteolytic activity
02/01/2011CA2315717C Inhibition of raf kinase using substituted heterocyclic ureas
01/2011
01/27/2011US20110021633 Antagonists of the Magnesium Binding Defect as Therapeutic Agents and Methods for Treatment of Abnormal Physiological States
01/27/2011US20110021448 Inhibitors for the Soluble Epoxide Hydrolase
01/26/2011EP2276749A1 Method for producing a compound with at least one at least monosubstituted amino group
01/25/2011US7875693 Synthesis of biurets and isocyanates with alkoxysilane functions, formulations containing same and use thereof
01/20/2011WO2010120138A3 Chiral salicylaldehyde compound and chiral naphtholaldehyde compound for l / d optical transformation of amino acid, and optical resolution of amino acid and aminoalcohol
01/19/2011EP2275395A2 Copper-catalyzed formation of carbon-carbon bonds
01/19/2011CN201711138U Urea synthesis reactor porous plate
01/19/2011CN101952243A 4-dimethylaminobutyric acid derivatives
01/19/2011CN101003499B Novel color former and recording material
01/18/2011CA2331460C Heterocyclic inhibitors of p38
01/13/2011WO2010112946A4 Adamantane bisurea derivatives, method of preparation and application in anion sensing
01/13/2011US20110009631 Phenethanolamine Derivatives for Treatment of Respiratory Diseases
01/12/2011EP2272813A2 Copper-catalyzed formation of carbon-oxygen bonds
01/12/2011CN201704243U Recovery equipment of hydrolysis desorption energy
01/12/2011CN1826098B Production of small particles
01/12/2011CN101942357A Method for isolating jatropha curcas oil polyunsaturated fatty acids
01/11/2011US7868204 Inhibitors of histone deacetylase
01/11/2011CA2641544C Process for producing o-methyl-n-nitroisourea
01/11/2011CA2373887C Polyisocyanates containing acylurea groups, a process for their production and their use
01/06/2011WO2011001122A2 Pyrazole derivatives, preparation thereof, and therapeutic use thereof
01/06/2011WO2010129057A3 Tetracycline compounds
01/06/2011CA2767096A1 Pyrazole derivatives, preparation thereof, and therapeutic use thereof
01/05/2011EP2268611A2 Aminoalkylphenyl antagonists of prostaglandin d2 receptors
01/05/2011EP2268610A1 Method for producing a compound with at least one at least monosubstituted amino group
01/05/2011EP2268606A1 4-dimethylaminobutyric acid derivatives
01/05/2011CN101939291A Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor
01/04/2011US7863333 asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis; Azetidine-1-carboxylic acid {2-[({2-hydroxy-1-[(isopropyl-methyl-amino)-methyl]-pentylcarbamoyl}-methyl)-carbamoyl]-4-trifluoromethyl-phenyl}-amide
01/04/2011US7863332 peroxisome proliferator activated receptor agonists, such as (E)-3-[3'-(3-heptyl-1-methylureido)biphenyl-4-yl]acrylic acid, useful in human or veterinary medicine (in dermatology, cardiovascular diseases, immune diseases and/or metabolism of lipids); cosmetics
01/04/2011CA2427750C Substituted alkanoic acids
12/2010
12/29/2010WO2010150255A1 Conjugates of cytotoxic drugs
12/29/2010WO2010132670A3 Pentacycline compounds
12/29/2010CN101932557A Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof
12/29/2010CN101932555A Process for the preparation of urethanes
12/29/2010CA2765462A1 Mexiletine amino acid and peptide prodrugs and uses thereof
12/28/2010US7858600 Non-antibiotic resistant; Gram-positive and Gram-negative bacteria; Salmonella, Streptococcus, Escherichia
12/23/2010US20100324025 Antibacterial Agents
12/23/2010US20100324008 Psma binding ligand-linker conjugates and methods for using
12/22/2010EP2263998A1 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the beta2 adrenergic receptor
12/16/2010WO2010144055A1 Novel compounds and uses thereof
12/16/2010WO2010143409A1 Processes for production of optically active thiazolylalanine derivative and salt thereof
12/16/2010US20100317854 Novel aminodicarboxylic acid derivatives having pharmaceutical properties
12/16/2010CA2763167A1 Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds
12/15/2010EP1756037B1 Amino alcohol derivatives and their activity as renin inhibitors
12/15/2010CN101914042A Preparation method of nicarbazin midbody 4,4'- binitro sym-diphenylurea
12/15/2010CN101914041A Refining method for medicinal urea
12/14/2010CA2591566C Process for the preparation of an aminoalcohol
12/09/2010WO2010110555A3 Method for obtaining optically pure amino acids
12/09/2010US20100311980 Process for the Preparation of a RAF Kinase Inhibitor and Intermediates for Use in the Process
12/09/2010US20100311794 Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds
12/08/2010EP2258677A2 Histone deacetylase inhibitors and methods of use thereof
12/08/2010CN1984882B Phenol compound, reversible thermosensitive recording medium, reversible thermosensitive recording label, reversible thermosensitive recording member, image-processing apparatus and image-processing m
12/08/2010CN101555025B Preparation method of ammonia for coal-fired flue gas desulfurization and denitration by coproduction
12/08/2010CN101219972B Method for synthesizing symmetrical aryl urea compounds
12/08/2010CN101068791B Method for preparing salt with tetrafluoroborate anion and reducing the content of hologenate
12/07/2010CA2460693C Alkyl urea retinoid agonists i
12/02/2010US20100305207 Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof
12/02/2010CA2763589A1 N,n'-diarylurea compounds and n,n'-diarylthiourea compounds as inhibitors of translation initiation
12/01/2010EP2254860A1 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the b2 adrenergic receptor
12/01/2010CN201660577U Melamine tail gas recycling device
12/01/2010CN201660575U Novel urea ammonia cooling device
12/01/2010CN101035758B Phenyl derivatives and methods of use
11/2010
11/30/2010US7842835 Increasing sensitivity of cancer cells to radiotherapy cytotoxic effects; neurological diseases; such as n-hydroxy-4-[3-(2-hydroxy-2-phenyl-ethyl)-ureido]-butyramide
11/30/2010US7842705 Curcumin analogs with anti-tumor and anti-angiogenic properties
11/30/2010CA2477208C Substituted phenylalkanoic acid derivatives and use thereof
11/24/2010EP1280764B1 Inhibitors of histone deacetylase
11/24/2010CN101891653A Clean production method of symmetric N,N'-disubstituted urea
11/23/2010US7838520 Inhibitors of histone deacetylase
11/23/2010CA2438870C Novel inhibitors of formation of advanced glycation endproducts (ages)
11/18/2010WO2010112946A9 Adamantane bisurea derivatives, method of preparation and application in anion sensing
11/17/2010CN101888994A Polyisocyanates containing allophanate groups
11/11/2010WO2010128062A1 O-imino-iso-urea compounds and polymerizable compositions thereof
11/11/2010WO2010127558A1 Substituted benzoyl urea compounds, preparation methods and uses thereof
11/11/2010CA2761241A1 Tetracycline compounds
11/10/2010CN101883754A High adhesive acrylate monomer and method for preparing the same
11/10/2010CN101880246A Substituted benzoyl urea compound and preparation method and application thereof
11/10/2010CN101880245A Method for purifying citrulline from watermelon
11/04/2010US20100280124 Acyl-urea derivatives and uses thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 99